LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.003
 71.78 27.76 1877 6893 0.2723 0.6983
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 71.78 27.76 2954 6893 0.4285 0.7979
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 71.78 27.76 654 6893 0.0949 0.4875
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 71.78 27.76 4754 6893 0.6897 0.9088
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 73.48 27.76 412 6957 0.0592 0.4028
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 73.48 27.76 3999 6957 0.5748 0.8657
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 73.48 27.76 1808 6957 0.2599 0.6889
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 73.48 27.76 2995 6957 0.4305 0.7993
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 73.48 27.76 678 6957 0.0974 0.4933
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 73.48 27.76 4950 6957 0.7114 0.9164
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 75.19 27.76 441 7015 0.0629 0.4141
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 75.19 27.76 4084 7015 0.5822 0.8689
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 75.19 27.76 1798 7015 0.2563 0.6864
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 75.19 27.76 3028 7015 0.4316 0.8002
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 75.19 27.76 725 7015 0.1034 0.5050
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 75.19 27.76 5032 7015 0.7173 0.9185
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 76.89 27.76 480 7025 0.0683 0.4291
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 76.89 27.76 4207 7025 0.5988 0.8756
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 76.89 27.76 1665 7025 0.2370 0.6700
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 76.89 27.76 3062 7025 0.4359 0.8024
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 76.89 27.76 708 7025 0.1008 0.5004
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 76.89 27.76 5204 7025 0.7408 0.9262
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 78.60 27.76 500 7045 0.0710 0.4361
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 78.60 27.76 4345 7045 0.6167 0.8826
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 78.60 27.76 1496 7045 0.2123 0.6473
MN20160318_Q01
H05